Equillium, Inc. Files 8-K on Material Agreements and Financials
Ticker: EQ · Form: 8-K · Filed: Aug 4, 2025 · CIK: 1746466
| Field | Detail |
|---|---|
| Company | Equillium, INC. (EQ) |
| Form Type | 8-K |
| Filed Date | Aug 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-results, regulation-fd
TL;DR
Equillium dropped an 8-K detailing material agreements and financials. Check it out.
AI Summary
Equillium, Inc. filed an 8-K on August 4, 2025, reporting on an entry into a material definitive agreement, results of operations, and other events. The filing details financial conditions and regulatory disclosures for the company, which is involved in pharmaceutical preparations.
Why It Matters
This 8-K filing provides crucial updates on Equillium's material agreements and financial performance, which could impact investor decisions and the company's strategic direction.
Risk Assessment
Risk Level: medium — 8-K filings often contain material information that can significantly impact a company's stock price, requiring careful investor attention.
Key Numbers
- 20250803 — Earliest Event Date (Date of earliest event reported in the 8-K)
- 20250804 — Filing Date (Date the 8-K was filed with the SEC)
Key Players & Entities
- Equillium, Inc. (company) — Registrant
- 20250803 (date) — Earliest event reported
- 20250804 (date) — Filing date
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
- 001-38692 (company_id) — SEC File Number
FAQ
What specific material definitive agreement was entered into by Equillium, Inc.?
The filing indicates an 'Entry into a Material Definitive Agreement' as an item, but the specific details of the agreement are not provided in the excerpt.
What are the key aspects of Equillium's results of operations and financial condition reported?
The filing lists 'Results of Operations and Financial Condition' as an item, but the specific financial details are not included in this excerpt.
What is the Standard Industrial Classification (SIC) code for Equillium, Inc.?
The SIC code for Equillium, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
When is Equillium, Inc.'s fiscal year end?
Equillium, Inc.'s fiscal year ends on December 31 (1231).
What is the principal executive office address for Equillium, Inc.?
The principal executive offices are located at 2223 Avenida de la Playa, Suite 105, La Jolla, CA 92037.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 4, 2025 regarding Equillium, Inc. (EQ).